Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Study reveals key links between arm endurance and pain in paraplegia

NCT ID NCT07154472

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at 32 wheelchair users with paraplegia to understand how arm endurance, fine motor skills, and symptoms like pain and weakness are connected. Participants completed tests of arm function and reported their symptoms. The goal was to find relationships that could help improve rehabilitation for people with spinal cord injuries.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

32 people

The number who actually took part.

Started

Jan 2025

Finished

Oct 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study was conducted on individuals with paraplegia who applied to the İstinye University Physiotherapy and Rehabilitation Research and Application Center (İSÜFİZYOTEM).

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Individuals with paraplegia who use a wheelchair * Classified as ASIA Impairment Scale grade A, B, or C * Fully or partially dependent on a wheelchair * Over 18 years of age * Possessing sufficient upper extremity muscle strength required for wheelchair use Exclusion Criteria: * Individuals with spinal cord injuries outside the T6-T12 levels * Presence of respiratory system diseases * Presence of cognitive impairment

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Endurance are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Istinye University Physiotherapy and Rehabilitation Practice and Research Center

    Istanbul, ZEYTINBURNU, 34000, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.